CNW/ -- (SSE: 603087) today announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, evaluating ...

SUPER-1 evaluated GZR4 in insulin-naïve Chinese adults with T2DM, while SUPER-2 assessed those previously treated with basal insulin.

Researchers in Japan have reported a significant step in the long‑standing scientific effort to develop an insulin medication ...

Most types of insulin therapy, an important part of diabetes treatment for many people, are given as daily injections to help manage blood sugar levels. Now, the maker of a once-weekly insulin ...

Insulin remains one of the most important treatments for people living with diabetes. Whether someone has Type 1 diabetes or advanced Type 2 diabetes, insulin therapy helps control blood sugar levels, ...

The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...

Algorithm with glucose monitor improves insulin dosing and boosts time in safe blood sugar range in type 2 diabetes.

Peptides are increasingly shaping the future of modern medicine. These short chains of amino acids function as signaling molecules throughout the body, helping regulate processes ...

Presentations on insulin therapy in type 2 diabetes from the 2023 annual meeting of the American Diabetes Association are presented by Dr Carol Wysham from the University of Washington School of ...

“Once-weekly IcoSema achieved noninferior A1c reduction and superiority in change in bodyweight, weekly total insulin dose, and hypoglycemia rates vs daily BBT [basal-bolus therapy], suggesting that ...